echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Infection: Impact of multidrug-resistant Acinetobacter baumannii infection on outcomes of COVID-19 patients hospitalized in the intensive care unit

    Infection: Impact of multidrug-resistant Acinetobacter baumannii infection on outcomes of COVID-19 patients hospitalized in the intensive care unit

    • Last Update: 2022-03-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Since the end of 2019, coronavirus disease 2019 ( COVID-19 ), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread globally, affecting people all over the world


     


     


    Figure: Impact of multidrug-resistant Acinetobacter baumannii infection on outcomes of COVID-19 patients hospitalized in the intensive care unit

     


    The results of this study demonstrate the prognostic impact of BSI in patients with COVID-19, that Acinetobacter baumannii colonization and steroid use are associated with an increased risk of MDR-AB infection during COVID-19


     

    Original source:

    Alessandro Russo.


    Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.


    Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.